Where BioNixus was built — and still leads.

    Pharma & Healthcare Market Research

    Pharmaceutical and healthcare research is the discipline BioNixus was founded on in 2012, and it remains the core of the firm. Everything else we do in B2B and B2C markets borrows the standards we set here: verified respondents, defensible sampling, and evidence built for a decision rather than a slide library.

    This page sits inside the BioNixus across-industries hub, which links our pharmaceutical and healthcare work to the broader B2B and B2C research we run for the same clients.

    How we approach pharma & healthcare research

    This is the home silo for life-sciences buyers. If your work touches a molecule, a device, a diagnosis, or a pharmacy shelf, the pages below connect to deep country and therapy coverage — physician and HCP surveys, KOL and payer research, market access and HTA support, real-world evidence, and launch readiness across the EU5, the GCC, North Africa, and the Americas.

    BioNixus is US-headquartered in Sheridan, Wyoming, with research operations in London and Cairo. That footprint lets us run American and European programmes to the same standard as our MENA fieldwork, and to benchmark a launch across all three regions inside one evidence framework.

    Who briefs us

    Who briefs us here: medical affairs, commercial and brand teams, market access and HEOR leads, MedTech and diagnostics marketers, biotech founders preparing for launch, and consumer-health teams sizing OTC and pharmacy demand.

    Industries we cover in this segment

    Each industry has dedicated country pages for Saudi Arabia, the UAE, and Egypt. Follow a link to the market you are planning for, or start from the full industries index.

    FAQs

    What pharmaceutical and healthcare research does BioNixus run?

    Quantitative physician and HCP surveys, qualitative KOL and payer interviews, market access and HTA support, competitive intelligence, real-world evidence, and launch readiness — across the EU5, the GCC, North Africa, and the Americas.

    Does BioNixus cover the United States and the Americas for healthcare?

    Yes. BioNixus is US-headquartered in Sheridan, Wyoming, and runs healthcare and medical-device research across the United States, Canada, and Brazil, with the same governance applied to our EMEA and GCC programmes.

    How is the Pharma & Healthcare section different from the B2B and B2C sections?

    This section carries the regulated, clinical, and access-driven work — pharma, MedTech, biotech, and consumer health. The B2B and B2C sections apply the same research rigor to non-healthcare categories. The BioNixus industries hub links all three.

    Talk with BioNixus research specialists

    Our team supports pharmaceutical companies with decision-ready insights across MENA, UK, and Europe using quantitative and qualitative methodologies.

    US No. +1 888 465 5557Europe No. +44 7727 666682Middle East, Africa and Asia No. +20 120 688 2323

    Request a proposal